 |
|
|
| |
Adults With Renal Impairment Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Have Improved Renal and Bone Safety Through 144 Weeks
|
| |
| |
Reported by Jules Levin
IAS 2017, July 23–26, 2017, Paris, France
Daniel Podzamczer,1 Jose Arribas,2 Amanda Clarke,3 Laurent Cotte,4 Tatiana
Mudrikova,5 Eugenia Negredo,6 William R. Short,7 Shuping Jiang,8 Andrew Cheng,8 Moupali Das8
1Hospital Universitari de Bellvitge, Barcelona, Spain; 2Hospital Universitario La Paz, Madrid, Spain; 3Brighton and Sussex University Hospitals NHS Trust, Brighton, UK; 4Hopital de La Croix-Rousse, Rhone, France; 5Universitair Medisch Centrum Utrecht, Netherlands; 6Hospital Germans Trias i Pujol, Barcelona, Spain; 7University of Pennsylvania, Philadelphia, USA; 8Gilead Sciences, Inc., Foster City, California, USA
|
| |
|
|
|
|
|
